Compare · ILMN vs SQL
ILMN vs SQL
Side-by-side comparison of Illumina Inc. (ILMN) and SeqLL Inc. (SQL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ILMN and SQL operate in Medical Specialities (Health Care), so they compete in similar markets.
- ILMN is the larger of the two at $24.58B, about 1342.9x SQL ($18.3M).
- ILMN has hit the wire 24 times in the past 4 weeks while SQL has been quiet.
- ILMN has more recent analyst coverage (25 ratings vs 1 for SQL).
- Company
- Illumina Inc.
- SeqLL Inc.
- Price
- $162.43+1.51%
- $7.26-15.58%
- Market cap
- $24.58B
- $18.3M
- 1M return
- +14.03%
- -
- 1Y return
- +85.49%
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2000
- 2021
- News (4w)
- 24
- 0
- Recent ratings
- 25
- 1
Illumina Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.
Latest ILMN
- Illumina upgraded by Analyst with a new price target
- SVP, Chief People Officer Leckman Patricia sold $127,305 worth of shares (783 units at $162.59), decreasing direct ownership by 4% to 21,259 units (SEC Form 4)
- Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution
- SVP, Chief People Officer Leckman Patricia sold $127,068 worth of shares (784 units at $162.08), decreasing direct ownership by 3% to 22,042 units (SEC Form 4)
- Director Meister Keith A. sold $107,042,631 worth of shares (669,596 units at $159.86) (SEC Form 4)
- Chief Legal Officer Davies Scott M sold $98,400 worth of shares (615 units at $160.00), decreasing direct ownership by 3% to 21,568 units (SEC Form 4)
- VP, Chief Accounting Officer Ericksen Scott D sold $305,150 worth of shares (2,000 units at $152.57), decreasing direct ownership by 12% to 14,446 units (SEC Form 4)
- Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights
- Amendment: SEC Form 4 filed by Director Meister Keith A.
- Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research
Latest SQL
- Atlantic International Corp. Acquires Lyneer Staffing Solutions
- SEC Form EFFECT filed by SeqLL Inc.
- SEC Form S-1/A filed by SeqLL Inc. (Amendment)
- SEC Form S-1/A filed by SeqLL Inc. (Amendment)
- SEC Form S-1/A filed by SeqLL Inc. (Amendment)
- SEC Form S-1/A filed by SeqLL Inc. (Amendment)
- SeqLL Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form S-1/A filed by SeqLL Inc. (Amendment)
- SEC Form S-1/A filed by SeqLL Inc. (Amendment)
- SEC Form 10-Q filed by SeqLL Inc.